Technology area: Chemistry & Materials
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Abbott Rapid Diagnostics International Unlimited Company currently manages 3 pending office actions within the Chemistry & Materials technology area. These matters are distributed across 2 distinct art units, indicating a concentrated focus for their intellectual property efforts. The portfolio involves 2 distinct examiners, which suggests a relatively narrow set of interactions with the patent office. This concentration in 2 distinct art units and 2 distinct examiners means that the company's prosecution strategy is highly dependent on a small number of office personnel.
SAMUEL P SIEFKE is identified as the busiest examiner for this company, personally handling 2 pending office actions. This represents a significant portion of the total 3 pending actions for the portfolio. Practitioners should note that the workload is split between only 2 distinct examiners, making individual examiner tendencies highly relevant to the overall prosecution strategy. With 2 pending office actions under a single examiner, the outcome of a majority of the company's current applications rests with SAMUEL P SIEFKE.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
| Double-patenting only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SIEFKE, SAMUEL P | 2 | 63.0% | +17.8% |
| BRAZIN, JACQUELINE | 1 | 65.6% | +52.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17784173 | ASSAY DEVICE | BRAZIN, JACQUELINE | 35d overdue |
| 17922399 | SAMPLE COLLECTION AND DISPOSAL SWAB | SIEFKE, SAMUEL P | 26d |
| 18671282 | DEVICE FOR DETECTING ANALYTE IN SAMPLE | SIEFKE, SAMUEL P | — |
| Art Unit | Apps |
|---|---|
| 1758 | 2 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18671282 | DEVICE FOR DETECTING ANALYTE IN SAMPLE | SIEFKE, SAMUEL P | 1758 | DP | Non-Final OA | — | Pending | May 22, 2024 |
| 17922399 | SAMPLE COLLECTION AND DISPOSAL SWAB | SIEFKE, SAMUEL P | 1758 | §102 | Final Rejection | 26d | Pending | Oct 31, 2022 |
| 17784173 | ASSAY DEVICE | BRAZIN, JACQUELINE | 1798 | §103 | Final Rejection | 35d overdue | Pending | Jun 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAbbott Rapid Diagnostics International Unlimited Company has 3 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Samuel P Siefke has the most, with 2 of Abbott Rapid Diagnostics International Unlimited Company's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
